Biomark Diagnostics Inc. (BMKDF)
OTCMKTS · Delayed Price · Currency is USD
0.3449
+0.0201 (6.19%)
At close: Dec 18, 2025
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 6.87K CAD in the quarter ending September 30, 2025, a decrease of -82.08%. This brings the company's revenue in the last twelve months to 123.42K, down -21.89% year-over-year. In the fiscal year ending March 31, 2025, Biomark Diagnostics had annual revenue of 154.22K, down -5.52%.
Revenue (ttm)
123.42K CAD
Revenue Growth
-21.89%
P/S Ratio
419.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.13M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 154.22K | -9.00K | -5.52% |
| Mar 31, 2024 | 163.22K | 9.73K | 6.34% |
| Mar 31, 2023 | 153.49K | 109.56K | 249.38% |
| Mar 31, 2022 | 43.93K | - | - |
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Biomark Diagnostics News
- 5 days ago - BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program - Newsfile Corp
- 27 days ago - BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala - Newsfile Corp
- 6 weeks ago - BioMark Aligns with National Strategy to Slash Lung Cancer Mortality with Next-Gen Liquid Biopsy - Newsfile Corp
- 2 months ago - BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial - Newsfile Corp
- 3 months ago - BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy - Newsfile Corp
- 4 months ago - BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership - Newsfile Corp
- 5 months ago - BioMark Diagnostics Announces Expansion of Its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International Partnerships - Newsfile Corp
- 5 months ago - BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 - 2026 - Newsfile Corp